Theradaptive, based in Frederick, MD, is a pioneering biotechnology company that utilizes advanced protein engineering to develop safer and more effective therapeutics. By enhancing the delivery of proteins, Theradaptive aims to address unmet medical needs and improve patient outcomes, particularly in cases where precise targeted delivery is required.
Driven by the desire to improve the lives of millions suffering from tissue function loss, Theradaptive has developed numerous material binding variants of recombinant proteins for a wide range of clinical indications. From spinal fusion and orthopedics to soft tissue repair and targeted chemotherapeutics, their modified proteins overcome current limitations and enable safer, long-term delivery, offering hope for patients in need.
Generated from the website